Sonoma Pharmaceuticals (SNOA) Times Interest Earned (2010 - 2021)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Times Interest Earned of -$904.0 in Q2 2021, down 3175.36% quarter-over-quarter from -$27.6 in Q4 2020.
Sonoma Pharmaceuticals (SNOA) Times Interest Earned (2010 - 2021) Analysis & Trends
Sonoma Pharmaceuticals' Times Interest Earned history runs 12 years deep, the most recent figure standing at -$904.0 for Q2 2021.
- In Q2 2021, Times Interest Earned changed N/A year-over-year to -$904.0; the TTM figure through Mar 2022 stood at -$5886.0 (down 1436.37% YoY), while the FY2021 annual figure was -$287.42, up 37.77% from the prior year.
- Times Interest Earned was -$904.0 for Q2 2021 at Sonoma Pharmaceuticals, down from -$27.6 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $42.25 in Q3 2020 to a low of -$2912.0 in Q1 2017.
- Historically, Times Interest Earned has averaged -$602.75 across 5 years, with a median of -$358.58 in 2017.
- The sharpest annual moves came in 2019 and 2020: Times Interest Earned slumped 230.04% in 2019, then jumped 106.57% in 2020.
- A 5-year view of Times Interest Earned shows it stood at -$290.91 in 2017, then retreated by 15.4% to -$335.71 in 2018, then tumbled by 230.04% to -$1108.0 in 2019, then soared by 97.51% to -$27.6 in 2020, then plunged by 3175.36% to -$904.0 in 2021.
- The last three Times Interest Earned figures came in at -$904.0 (Q2 2021), -$27.6 (Q4 2020), and $42.25 (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -904.00 |
| Dec 31, 2020 | -27.60 |
| Sep 30, 2020 | 42.25 |
| Mar 31, 2020 | -1,074.67 |
| Dec 31, 2019 | -1,108.00 |
| Sep 30, 2019 | -643.50 |
| Jun 30, 2019 | -177.10 |
| Mar 31, 2019 | -386.29 |
| Dec 31, 2018 | -335.71 |
| Sep 30, 2018 | -378.86 |
| Jun 30, 2018 | -296.00 |
| Mar 31, 2018 | -527.67 |
| Dec 31, 2017 | -290.91 |
| Sep 30, 2017 | -285.70 |
| Jun 30, 2017 | -338.30 |
| Mar 31, 2017 | -2,912.00 |
| Sep 30, 2016 | -2,986.00 |
| Jun 30, 2016 | -3,509.00 |
| Mar 31, 2016 | -1,807.50 |
| Sep 30, 2015 | -1,858.00 |